Cardiac complications of anticancer therapy represent an emerging clinical issue in both established chemotherapeutics as well as novel molecular therapies. As a result, healthcare providers are under greater pressure to be vigilant in evaluating patients with cancer for acute and chronic or late physical effects of cancer therapy -- some of which could be life-threatening. Cardiac Complications of Cancer Therapy, edited by Anecita P. Fadol, PhD, RN, FNP-BC, FAANP, provides you with the essentials of clinical management of the most common cardiac complications of cancer therapy. While you can find a multitude of literature on the management of cardiac problems, including both texts and journal articles, no other clinical reference book on the current market is written for nurses and midlevel providers and examines both the complexity of cardiac problems in conjunction with a cancer diagnosis. Describing the assessment and management of common cardiac problems, chapters in this quick-reference guide examine issues such as cardiovascular anatomy, the development of cardiotoxicity and the management of cardiomyopathy in patients with cancer, targeted therapies and cardiomyopathy, acute coronary syndromes in patients with cancer, cardiac inflammatory conditions and cardiac tamponade in patients with cancer, hypertension in patients with cancer, heart failure in patients with cancer, screening and management of cardiovascular risk factors in cancer survivors, and much more.